Additional file 1: of Mass spectrometry-based analysis of cerebrospinal fluid from arthritis patients—immune-related candidate proteins affected by TNF blocking treatment

Table S1. Proteins significantly altered in CSF of polyarthritis patients after 8 weeks of infliximab treatment identified by unbiased label-free proteomic profiling and analysed by Wilcoxon signed rank test. Table S2. Full list of proteins detected in proteomic assay. Treatment effect was tested by Wilcoxon signed rank test for paired polyarthritis samples at baseline and after 8 weeks of infliximab treatment. p < 0.05 are marked in red. Table S3. Proteins detected by proteomic profiling contributing the most to the separation of arthritis CSF samples at baseline and after 8 weeks of infliximab treatment. Table S4. Proteins detected in proteomic profiling in CSF of polyarthritis patients overlapping with proteins detected in CSF in other diseases as well as proteins identified as differentially expressed or regulated in these diseases. (XLSX 58 kb)